https://www.selleckchem.com/products/Axitinib.html
We investigated, whether epileptic seizures (ES) as presenting symptom in adult patients with GBM are associated with better Overall Survival (OS) compared to ES presenting later during the course of GBM, and efficacy and safety of different antiseizure medications (ASMs). Retrospective consecutive cohort study of adults with GBM 50 from Norway and 50 from Italy. We compared the time to changing ASM treatments. OS was investigated with a Cox regression model adjusted for time dependency. Median follow-up was 17 months from GBM diagnosi
Curtir
Comentario
Compartilhar
